Erasca (ERAS) Cash & Equivalents (2020 - 2026)

Erasca (ERAS) posted Cash & Equivalents of $47.3 million for Q1 2026, down 35.97% on a QoQ basis from $73.8 million in Q4 2025, and down 32.95% year-over-year from $70.5 million in Q1 2025.

Erasca (ERAS) Cash & Equivalents (2020 - 2026) Analysis & Trends

Erasca's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $47.3 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 32.95% year-over-year to $47.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.3 million (down 32.95% YoY) and the FY2025 annual result came in at $73.8 million, up 8.95% from the prior year.
  • Cash & Equivalents was $47.3 million for Q1 2026 at Erasca, down from $73.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $333.3 million in Q1 2022 and bottomed at $47.3 million in Q1 2026.
  • A 5-year average of $146.1 million and a median of $112.9 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 96.1% — and 2023, when it sank 67.25%.
  • Erasca's Cash & Equivalents stood at $284.2 million in 2022, then sank by 67.25% to $93.1 million in 2023, then decreased by 27.22% to $67.7 million in 2024, then gained by 8.95% to $73.8 million in 2025, then tumbled by 35.97% to $47.3 million in 2026.
  • Business Quant data shows ERAS's Cash & Equivalents at $47.3 million in Q1 2026, $73.8 million in Q4 2025, and $70.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Erasca 5.89 Bn 5.89 Bn - 47.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.26 Mn
Dec 31, 2025 73.81 Mn
Sep 30, 2025 70.23 Mn
Jun 30, 2025 66.14 Mn
Mar 31, 2025 70.48 Mn
Dec 31, 2024 67.74 Mn
Sep 30, 2024 68.89 Mn
Jun 30, 2024 172.80 Mn
Mar 31, 2024 172.80 Mn
Dec 31, 2023 93.08 Mn
Sep 30, 2023 112.86 Mn
Jun 30, 2023 138.79 Mn
Mar 31, 2023 272.76 Mn
Dec 31, 2022 284.22 Mn
Sep 30, 2022 219.26 Mn
Jun 30, 2022 219.26 Mn
Mar 31, 2022 333.35 Mn
Dec 31, 2021 360.49 Mn
Sep 30, 2021 445.81 Mn
Jun 30, 2021 156.40 Mn